Free Analysis

Data-driven stock analysis, valuation deep dives, and financial forensics. Every article backed by the numbers.

RiskCRWD

Revisiting CrowdStrike: The Outage Risk Faded but the Valuation Risk Returned

Customer churn from the July 2024 outage has been negligible, but at 80x earnings and 15x revenue, CrowdStrike is priced for perfection again.

Apr 12, 2026
Capital AllocationJPM

Updating Our JPMorgan Thesis After Q1 Earnings Beat Expectations

Net interest income defied rate-cut models, investment banking fees surged, and normalised earnings now look closer to $52-55 billion than our prior $45-48 billion estimate.

Apr 12, 2026
Market SignalsSNOW

Four Things the Market Is Missing About Snowflake

Net retention has stabilised, AI workloads are inflecting at 300% growth, FCF margins hit 25%, and the CEO transition is behind it. The four biggest bear arguments are weakening.

Apr 12, 2026
Deep DivesMRK

KEYTRUDA's Expanding Reach Just Bought Merck More Time Than the Street Thinks

Merck's 40th KEYTRUDA indication and approaching MK-0616 FDA decision tell a story about the post-patent strategy that consensus models are underestimating.

Apr 12, 2026
Deep DivesAMZN

Amazon's Margin Transformation Is Hiding in Plain Sight

Operating income has grown sixfold since 2022. The market still thinks it is buying a retailer.

Apr 12, 2026
Market SignalsRIVN

EV Demand Is Cratering — Rivian Might Be the Only Startup That Survives It

Rivian just posted positive gross margins for the first time while EV sales fell 11% industry-wide. The Volkswagen JV and R2 platform launch change the survival calculus.

Apr 12, 2026
RiskJNJ

Why the Market Is Overpricing Johnson & Johnson's Defensive Premium

Post-Kenvue JNJ trades at 22x earnings with a looming Stelara patent cliff worth $4-5 billion in annual revenue. The defensive premium is priced for a company that no longer exists.

Apr 12, 2026
Deep DivesNFLX

Netflix: The Margin Machine Tariffs Cannot Touch

While hardware and chip stocks spent April repricing trade war exposure, Netflix had no supply chain to worry about. The real question is whether the margin transformation from 17.8% to 29.5% in three years justifies a 40x multiple.

Apr 11, 2026
Market SignalsDE

The Charts That Show Deere Is Becoming a Tech Company

Precision agriculture revenue has grown from $1.8B to $4.4B in four years while total revenue declined. The market is getting the tech transformation for free.

Apr 11, 2026
Capital AllocationHON

Honeywell's Breakup Would Unlock $40-50 Billion in Hidden Value

Elliott Management is pushing for a split. The sum-of-parts shows $180-200B in value versus a $150B market cap. The GE precedent makes the case.

Apr 11, 2026
Capital AllocationCOP

Revisiting ConocoPhillips After Marathon's Integration Beat

Marathon synergies are running 20% ahead of target. Production crossed 2 million BOE/d. We're raising our target to $145.

Apr 11, 2026
Market SignalsSQ

Cash App's Lending Business Just Crossed a Billion in Originations

Block's payments app is evolving into a full-service bank for 55 million underbanked Americans. The lending ramp is in its first inning.

Apr 11, 2026
Capital AllocationRTX

Five Reasons RTX Is the Most Undervalued Defence Stock

A $200B defence backlog, fading Pratt & Whitney charges, NATO spending tailwinds, and $36-40B in planned capital returns. The normalised PE is just 22-24x.

Apr 11, 2026
Deep DivesMRK

Inside Merck's Race to Replace $25 Billion in Keytruda Revenue

The 2028 patent cliff is the defining event for Merck's next decade. Tulisokibart, ADCs, and subcutaneous Keytruda are the three bets management is making.

Apr 11, 2026
RiskSHOP

Why the Street Is Too Bullish on Shopify's Valuation

At 20x forward revenue with Amazon embedding Buy with Prime into the platform and TikTok Shop growing fast, the consensus bull case ignores mounting competitive threats.

Apr 11, 2026